Clinical Trials in Arizona

Showing 4181-4200 of 16,770 trials

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

NCT03199586

Phase 1 A: First-in-human phase 1 study to determine safety of NP-G2-044 when given orally on a daily X 28 days followed by a 14 day rest period.

Breast CancerPancreas CancerProstate Cancer+6 more

Novita Pharmaceuticals, Inc.23 participantsStarted Dec 2017

Scottsdale, Arizona, United States • Duarte, California, United States • New York, New York, United States

COMPLETEDPhase 431 miles

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

NCT03915964

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.

Rheumatoid Arthritis

Eli Lilly and Company2,663 participantsStarted Apr 2019

Flagstaff, Arizona, United States • Gilbert, Arizona, United States • Glendale, Arizona, United States +258 more locations

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Find Trials by Condition in Arizona

ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral Total Knee Arthroplasty (TKA)

EXOMIND (BTL-699-2) for Improvement of Mental Well-being

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Secur-Fit Advanced Outcomes Study

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

Evaluation of Alcon Ladarvision Wavefront-Guided PRK

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis

Non-surgical Spinal Decompression Therapy and Outcomes